Literature DB >> 30449639

Management of meningioma.

Philipp Euskirchen1, Matthieu Peyre2.   

Abstract

Meningiomas are the most frequent primary brain tumors, accounting for ∼37% of central nervous systems tumors. Despite being largely benign, clinicians frequently face difficult treatment decisions in cases with complex morphology or localisation, near vital brain structures such as the optic nerve or in the case of incidental tumors. Here, we review current concepts of diagnosis, treatment and follow-up with clinical decision-making informed by multimodal imaging, histology, and molecular biology.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30449639     DOI: 10.1016/j.lpm.2018.05.016

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  12 in total

Review 1.  The Role of Surgery in Meningiomas.

Authors:  Michele Bailo; Filippo Gagliardi; Nicola Boari; Antonella Castellano; Alfio Spina; Pietro Mortini
Journal:  Curr Treat Options Neurol       Date:  2019-09-27       Impact factor: 3.598

2.  14th EUNOS Congress: PORTO, PORTUGAL, 16-19 JUNE 2019.

Authors: 
Journal:  Neuroophthalmology       Date:  2019-06-07

3.  Presurgical Identification of Primary Central Nervous System Lymphoma with Normalized Time-Intensity Curve: A Pilot Study of a New Method to Analyze DSC-PWI.

Authors:  A Pons-Escoda; A Garcia-Ruiz; P Naval-Baudin; M Cos; N Vidal; G Plans; J Bruna; R Perez-Lopez; C Majos
Journal:  AJNR Am J Neuroradiol       Date:  2020-09-17       Impact factor: 3.825

4.  Distinct clinical outcome of microcystic meningioma as a WHO grade 1 meningioma subtype.

Authors:  Leihao Ren; Lingyang Hua; Zhongyuan Bao; Hiroaki Wakimoto; Ye Gong; Jiaojiao Deng; Daijun Wang; Jiawei Chen; Hong Chen; Tareq A Juratli
Journal:  J Neurooncol       Date:  2022-05-25       Impact factor: 4.130

5.  miR-497 and 219 in blood aid meningioma classification.

Authors:  Ahmed Abdelrahman; Caterina Negroni; Felix Sahm; Claire L Adams; Tadeja Urbanic-Purkart; Michael Khalil; Raffaellla Vergura; Cristina Morelli; Clemens Oliver Hanemann
Journal:  J Neurooncol       Date:  2022-09-08       Impact factor: 4.506

6.  Postoperative radiotherapy for meningiomas - a decision-making analysis.

Authors:  Thomas Hundsberger; Paul Martin Putora; Galina Farina Fischer; Detlef Brügge; Nicolaus Andratschke; Brigitta Gertrud Baumert; Davide Giovanni Bosetti; Francesca Caparrotti; Evelyn Herrmann; Alexandros Papachristofilou; Susanne Rogers; Lucia Schwyzer; Daniel Rudolf Zwahlen
Journal:  BMC Cancer       Date:  2022-05-04       Impact factor: 4.638

Review 7.  Heme Oxygenase-1 in Central Nervous System Malignancies.

Authors:  Giuseppe Sferrazzo; Michelino Di Rosa; Eugenio Barone; Giovanni Li Volti; Nicolò Musso; Daniele Tibullo; Ignazio Barbagallo
Journal:  J Clin Med       Date:  2020-05-21       Impact factor: 4.241

8.  Characterization of Progesterone Receptor Expression in Intracranial Meningiomas of Patients Treated in a High-Complexity Hospital in Bogota, Colombia.

Authors:  Raul Ramirez Grueso; Linda Barcenas; Jaime A Arias; Carlos Colegial; Claudia L Avendaño; Jose Chaves; Jorge Galvis; Santiago Moreno
Journal:  Cureus       Date:  2020-12-29

Review 9.  Repurposing of Anticancer Stem Cell Drugs in Brain Tumors.

Authors:  Hisham F Bahmad; Darine Daher; Abed A Aljamal; Mohamad K Elajami; Kei Shing Oh; Juan Carlos Alvarez Moreno; Ruben Delgado; Richard Suarez; Ana Zaldivar; Roshanak Azimi; Amilcar Castellano; Robert Sackstein; Robert J Poppiti
Journal:  J Histochem Cytochem       Date:  2021-06-24       Impact factor: 2.479

10.  Gemcitabine in Recurrent Meningioma.

Authors:  Satvik Khaddar; Arti Bhelekar; Ochin Dale; Litty Varghese; Vijay Maruti Patil
Journal:  South Asian J Cancer       Date:  2021-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.